ID   MAGL2_HUMAN             Reviewed;        1249 AA.
AC   Q9UJ55; H0YDD5;
DT   18-OCT-2001, integrated into UniProtKB/Swiss-Prot.
DT   16-SEP-2015, sequence version 2.
DT   28-JUN-2023, entry version 123.
DE   RecName: Full=MAGE-like protein 2;
DE   AltName: Full=Necdin-like protein 1;
DE   AltName: Full=Protein nM15;
GN   Name=MAGEL2; Synonyms=NDNL1;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16572171; DOI=10.1038/nature04601;
RA   Zody M.C., Garber M., Sharpe T., Young S.K., Rowen L., O'Neill K.,
RA   Whittaker C.A., Kamal M., Chang J.L., Cuomo C.A., Dewar K.,
RA   FitzGerald M.G., Kodira C.D., Madan A., Qin S., Yang X., Abbasi N.,
RA   Abouelleil A., Arachchi H.M., Baradarani L., Birditt B., Bloom S.,
RA   Bloom T., Borowsky M.L., Burke J., Butler J., Cook A., DeArellano K.,
RA   DeCaprio D., Dorris L. III, Dors M., Eichler E.E., Engels R., Fahey J.,
RA   Fleetwood P., Friedman C., Gearin G., Hall J.L., Hensley G., Johnson E.,
RA   Jones C., Kamat A., Kaur A., Locke D.P., Madan A., Munson G., Jaffe D.B.,
RA   Lui A., Macdonald P., Mauceli E., Naylor J.W., Nesbitt R., Nicol R.,
RA   O'Leary S.B., Ratcliffe A., Rounsley S., She X., Sneddon K.M.B.,
RA   Stewart S., Sougnez C., Stone S.M., Topham K., Vincent D., Wang S.,
RA   Zimmer A.R., Birren B.W., Hood L., Lander E.S., Nusbaum C.;
RT   "Analysis of the DNA sequence and duplication history of human chromosome
RT   15.";
RL   Nature 440:671-675(2006).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 635-1249, AND TISSUE SPECIFICITY.
RX   PubMed=10915770; DOI=10.1093/hmg/9.12.1813;
RA   Lee S., Kozlov S., Hernandez L., Chamberlain S.J., Brannan C.I.,
RA   Stewart C.L., Wevrick R.;
RT   "Expression and imprinting of MAGEL2 suggest a role in Prader-Willi
RT   syndrome and the homologous murine imprinting phenotype.";
RL   Hum. Mol. Genet. 9:1813-1819(2000).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 638-1249.
RC   TISSUE=Brain, and Placenta;
RX   PubMed=10556298; DOI=10.1093/hmg/8.13.2497;
RA   Boccaccio I., Glatt-Deeley H., Watrin F., Roeckel N., Lalande M.,
RA   Muscatelli F.;
RT   "The human MAGEL2 gene and its mouse homologue are paternally expressed and
RT   mapped to the Prader-Willi region.";
RL   Hum. Mol. Genet. 8:2497-2505(1999).
RN   [4]
RP   FUNCTION, AND INTERACTION WITH TRIM27.
RX   PubMed=20864041; DOI=10.1016/j.molcel.2010.08.029;
RA   Doyle J.M., Gao J., Wang J., Yang M., Potts P.R.;
RT   "MAGE-RING protein complexes comprise a family of E3 ubiquitin ligases.";
RL   Mol. Cell 39:963-974(2010).
RN   [5]
RP   FUNCTION, INTERACTION WITH TRIM27 AND VPS35, AND SUBCELLULAR LOCATION.
RX   PubMed=23452853; DOI=10.1016/j.cell.2013.01.051;
RA   Hao Y.H., Doyle J.M., Ramanathan S., Gomez T.S., Jia D., Xu M., Chen Z.J.,
RA   Billadeau D.D., Rosen M.K., Potts P.R.;
RT   "Regulation of WASH-dependent actin polymerization and protein trafficking
RT   by ubiquitination.";
RL   Cell 152:1051-1064(2013).
RN   [6]
RP   INVOLVEMENT IN SHFYNG.
RX   PubMed=24076603; DOI=10.1038/ng.2776;
RA   Schaaf C.P., Gonzalez-Garay M.L., Xia F., Potocki L., Gripp K.W., Zhang B.,
RA   Peters B.A., McElwain M.A., Drmanac R., Beaudet A.L., Caskey C.T., Yang Y.;
RT   "Truncating mutations of MAGEL2 cause Prader-Willi phenotypes and autism.";
RL   Nat. Genet. 45:1405-1408(2013).
RN   [7]
RP   INTERACTION WITH USP7 AND TRIM27.
RX   PubMed=26365382; DOI=10.1016/j.molcel.2015.07.033;
RA   Hao Y.H., Fountain M.D. Jr., Fon Tacer K., Xia F., Bi W., Kang S.H.,
RA   Patel A., Rosenfeld J.A., Le Caignec C., Isidor B., Krantz I.D., Noon S.E.,
RA   Pfotenhauer J.P., Morgan T.M., Moran R., Pedersen R.C., Saenz M.S.,
RA   Schaaf C.P., Potts P.R.;
RT   "USP7 Acts as a Molecular Rheostat to Promote WASH-Dependent Endosomal
RT   Protein Recycling and Is Mutated in a Human Neurodevelopmental Disorder.";
RL   Mol. Cell 59:956-969(2015).
CC   -!- FUNCTION: Probably enhances ubiquitin ligase activity of RING-type zinc
CC       finger-containing E3 ubiquitin-protein ligases, possibly through
CC       recruitment and/or stabilization of the Ubl-conjugating enzyme (E2) at
CC       the E3:substrate complex. Acts as a regulator of retrograde transport
CC       via its interaction with VPS35. Recruited to retromer-containing
CC       endosomes and promotes the formation of 'Lys-63'-linked polyubiquitin
CC       chains at 'Lys-220' of WASHC1 together with TRIM27, leading to promote
CC       endosomal F-actin assembly (PubMed:23452853). Regulates the circadian
CC       clock by repressing the transcriptional activator activity of the
CC       CLOCK-BMAL1 heterodimer. Significantly promotes the cytoplasmic
CC       accumulation of CLOCK (By similarity). {ECO:0000250|UniProtKB:Q9QZ04,
CC       ECO:0000269|PubMed:20864041, ECO:0000269|PubMed:23452853}.
CC   -!- SUBUNIT: Part of a complex consisting of MAGEL2, TRIM27 and USP7;
CC       directly interacts with USP7 (PubMed:26365382). Interacts with TRIM27
CC       (PubMed:23452853). Interacts with VPS35; leading to recruitment at
CC       retromer-containing endosomes (PubMed:23452853). Interacts with BMAL1
CC       and PER2 (By similarity). {ECO:0000250|UniProtKB:Q9QZ04,
CC       ECO:0000269|PubMed:20864041, ECO:0000269|PubMed:23452853,
CC       ECO:0000269|PubMed:26365382}.
CC   -!- INTERACTION:
CC       Q9UJ55; P63010: AP2B1; NbExp=2; IntAct=EBI-5668174, EBI-432924;
CC       Q9UJ55; Q14192: FHL2; NbExp=3; IntAct=EBI-5668174, EBI-701903;
CC       Q9UJ55; Q9UMX1: SUFU; NbExp=3; IntAct=EBI-5668174, EBI-740595;
CC       Q9UJ55; Q93009: USP7; NbExp=2; IntAct=EBI-5668174, EBI-302474;
CC   -!- SUBCELLULAR LOCATION: Early endosome {ECO:0000269|PubMed:23452853}.
CC       Cytoplasm {ECO:0000250|UniProtKB:Q9QZ04}. Nucleus
CC       {ECO:0000250|UniProtKB:Q9QZ04}. Note=Recruited to retromer-containing
CC       endosomes via interaction with VPS35. Colocalizes with CLOCK and BMAL1
CC       in the cytoplasm, and with PER2 in the cytoplasm and nucleus (By
CC       similarity). {ECO:0000250|UniProtKB:Q9QZ04,
CC       ECO:0000269|PubMed:23452853}.
CC   -!- TISSUE SPECIFICITY: Expressed in placenta, fetal and adult brain. Not
CC       detected in heart and small intestine, very low levels in fibroblasts.
CC       Not expressed in brain of a Prader-Willi patient.
CC       {ECO:0000269|PubMed:10915770}.
CC   -!- DISEASE: Schaaf-Yang syndrome (SHFYNG) [MIM:615547]: A disease
CC       characterized by clinical features of Prader-Willi syndrome, including
CC       neonatal hypotonia with poor suck, feeding problems in infancy,
CC       obesity, developmental delay, short stature, and hypogonadism.
CC       Additionally, patients manifest autism spectrum disorder. Some patients
CC       have dysmorphic facial features. {ECO:0000269|PubMed:24076603}.
CC       Note=The disease is caused by variants affecting the gene represented
CC       in this entry. All mutations occurred on the paternal allele.
CC   -!- MISCELLANEOUS: Imprinted, expressed from the paternal chromosome only.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAG28577.1; Type=Frameshift; Evidence={ECO:0000305};
CC       Sequence=CAB62393.1; Type=Frameshift; Evidence={ECO:0000305};
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AC124309; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AF200625; AAG28577.1; ALT_FRAME; Genomic_DNA.
DR   EMBL; AJ243531; CAB62393.1; ALT_FRAME; mRNA.
DR   CCDS; CCDS73700.1; -.
DR   RefSeq; NP_061939.3; NM_019066.4.
DR   AlphaFoldDB; Q9UJ55; -.
DR   CORUM; Q9UJ55; -.
DR   IntAct; Q9UJ55; 5.
DR   STRING; 9606.ENSP00000433433; -.
DR   GlyGen; Q9UJ55; 1 site, 1 O-linked glycan (1 site).
DR   iPTMnet; Q9UJ55; -.
DR   PhosphoSitePlus; Q9UJ55; -.
DR   BioMuta; MAGEL2; -.
DR   DMDM; 17380152; -.
DR   EPD; Q9UJ55; -.
DR   MassIVE; Q9UJ55; -.
DR   MaxQB; Q9UJ55; -.
DR   PaxDb; Q9UJ55; -.
DR   PeptideAtlas; Q9UJ55; -.
DR   ProteomicsDB; 37358; -.
DR   ProteomicsDB; 84587; -.
DR   Antibodypedia; 58530; 107 antibodies from 13 providers.
DR   DNASU; 54551; -.
DR   Ensembl; ENST00000650528.1; ENSP00000497810.1; ENSG00000254585.5.
DR   Ensembl; ENST00000672700.1; ENSP00000499864.1; ENSG00000288188.1.
DR   Ensembl; ENST00000673192.1; ENSP00000500572.1; ENSG00000288188.1.
DR   GeneID; 54551; -.
DR   KEGG; hsa:54551; -.
DR   MANE-Select; ENST00000650528.1; ENSP00000497810.1; NM_019066.5; NP_061939.3.
DR   UCSC; uc001ywj.5; human.
DR   AGR; HGNC:6814; -.
DR   CTD; 54551; -.
DR   DisGeNET; 54551; -.
DR   GeneCards; MAGEL2; -.
DR   GeneReviews; MAGEL2; -.
DR   HGNC; HGNC:6814; MAGEL2.
DR   HPA; ENSG00000254585; Group enriched (brain, pituitary gland).
DR   MalaCards; MAGEL2; -.
DR   MIM; 605283; gene.
DR   MIM; 615547; phenotype.
DR   neXtProt; NX_Q9UJ55; -.
DR   OpenTargets; ENSG00000254585; -.
DR   Orphanet; 398069; MAGEL2-related Prader-Willi-like syndrome.
DR   Orphanet; 177910; Prader-Willi syndrome due to imprinting mutation.
DR   Orphanet; 98754; Prader-Willi syndrome due to maternal uniparental disomy of chromosome 15.
DR   Orphanet; 177901; Prader-Willi syndrome due to paternal deletion of 15q11q13 type 1.
DR   Orphanet; 177904; Prader-Willi syndrome due to paternal deletion of 15q11q13 type 2.
DR   VEuPathDB; HostDB:ENSG00000254585; -.
DR   eggNOG; KOG4562; Eukaryota.
DR   GeneTree; ENSGT00940000163006; -.
DR   InParanoid; Q9UJ55; -.
DR   OMA; TQVTWQA; -.
DR   OrthoDB; 3128316at2759; -.
DR   TreeFam; TF328505; -.
DR   PathwayCommons; Q9UJ55; -.
DR   SignaLink; Q9UJ55; -.
DR   SIGNOR; Q9UJ55; -.
DR   BioGRID-ORCS; 54551; 12 hits in 384 CRISPR screens.
DR   GenomeRNAi; 54551; -.
DR   Pharos; Q9UJ55; Tbio.
DR   PRO; PR:Q9UJ55; -.
DR   Proteomes; UP000005640; Chromosome 15.
DR   RNAct; Q9UJ55; protein.
DR   Bgee; ENSG00000254585; Expressed in adrenal tissue and 96 other tissues.
DR   GO; GO:0005829; C:cytosol; IEA:GOC.
DR   GO; GO:0005769; C:early endosome; IEA:UniProtKB-SubCell.
DR   GO; GO:0005768; C:endosome; IDA:UniProtKB.
DR   GO; GO:0005634; C:nucleus; ISS:UniProtKB.
DR   GO; GO:0004842; F:ubiquitin-protein transferase activity; IMP:UniProtKB.
DR   GO; GO:0034314; P:Arp2/3 complex-mediated actin nucleation; IDA:UniProtKB.
DR   GO; GO:0045892; P:negative regulation of DNA-templated transcription; ISS:UniProtKB.
DR   GO; GO:0000122; P:negative regulation of transcription by RNA polymerase II; IBA:GO_Central.
DR   GO; GO:0051127; P:positive regulation of actin nucleation; IEA:Ensembl.
DR   GO; GO:0070534; P:protein K63-linked ubiquitination; IMP:UniProtKB.
DR   GO; GO:0042752; P:regulation of circadian rhythm; ISS:UniProtKB.
DR   GO; GO:0042147; P:retrograde transport, endosome to Golgi; IDA:UniProtKB.
DR   GO; GO:0048511; P:rhythmic process; IEA:UniProtKB-KW.
DR   Gene3D; 1.10.10.1200; MAGE homology domain, winged helix WH1 motif; 1.
DR   Gene3D; 1.10.10.1210; MAGE homology domain, winged helix WH2 motif; 1.
DR   InterPro; IPR037445; MAGE.
DR   InterPro; IPR041898; MAGE_WH1.
DR   InterPro; IPR041899; MAGE_WH2.
DR   InterPro; IPR002190; MHD_dom.
DR   PANTHER; PTHR11736:SF66; MAGE-LIKE PROTEIN 2; 1.
DR   PANTHER; PTHR11736; MELANOMA-ASSOCIATED ANTIGEN MAGE ANTIGEN; 1.
DR   Pfam; PF01454; MAGE; 1.
DR   SMART; SM01373; MAGE; 1.
DR   PROSITE; PS50838; MAGE; 1.
PE   1: Evidence at protein level;
KW   Autism spectrum disorder; Biological rhythms; Cytoplasm; Endosome;
KW   Intellectual disability; Nucleus; Obesity; Reference proteome; Repressor;
KW   Transcription; Transcription regulation; Transport;
KW   Ubl conjugation pathway.
FT   CHAIN           1..1249
FT                   /note="MAGE-like protein 2"
FT                   /id="PRO_0000156738"
FT   DOMAIN          1020..1219
FT                   /note="MAGE"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00127"
FT   REGION          1..50
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          134..233
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          300..327
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          349..378
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          410..433
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          515..569
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          647..679
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          714..746
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          862..910
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          930..957
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          1226..1249
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        136..232
FT                   /note="Pro residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        307..325
FT                   /note="Pro residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        539..569
FT                   /note="Pro residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        649..679
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        726..746
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        862..876
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        889..903
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
SQ   SEQUENCE   1249 AA;  132822 MW;  17AA2FB3F8477D82 CRC64;
     MSQLSKNLGD SSPPAEAPKP PVYSRPTVLM RAPPASSRAP PVPWDPPPID LQASLAAWQA
     PQPAWEAPQG QLPAPVVPMT QPPALGGPIV PAPPLGGPMG KPPTPGVLMV HPPPPGAPMA
     QPPTPGVLMV HPSAPGAPMA HPPPPGTPMS HPPPPGTPMA HPPPPGTPMA HPPPPGTPMV
     HPPPPGTPMA HPPPPGTPMA HPPPPGTPMA HPPPPGTPMA HPPPPGTPMA QPPAPGVLMA
     QPLTPGVLMV QPAAPGAPMV QPPPAAMMTQ PQPSGAPMAK PPGPGVLMIH PPGARAPMTQ
     PPASGAPMAQ PAAPPAQPMA PPAQPMASWA PQAQPLILQI QSQVIRAPPQ VPQGPQAPPA
     QLATPPGWQA TSPGWQATQQ GWQATPLTWQ TTQVTWQAPA VTWQVPPPMR QGPPPIRPGP
     PPIRPGPPPV RQAPPLIRQA PPVIRQAPPV IRQAPPVIRQ APAVIRQAPP VIRQAPPVIR
     QAPPVIRQAP PLIRQAPPPI RPAPQVLATQ PPLWQALPPP PPLRQAPQAR LPAPQVQAAP
     QVPTAPPATQ VPAAPPAGPQ VPQPVLPAPL SAPLSAPQAV HCPSIIWQAP KGQPPVPHEI
     PTSMEFQEVQ QTQALAWQAQ KAPTHIWQPL PAQEAQRQAP PLVQLEQPFQ GAPPSQKAVQ
     IQLPPQQAQA SGPQAEVPTL PLQPSWQAPP AVLQAQPGPP VAAANFPLGS AKSLMTPSGE
     CRASSIDRRG SSKERRTSSK ERRAPSKDRM IFAATFCAPK AVSAARAHLP AAWKNLPATP
     ETFAPSSSVF PATSQFQPAS LNAFKGPSAA SETPKSLPYA LQDPFACVEA LPAVPWVPQP
     NMNASKASQA VPTFLMATAA APQATATTQE ASKTSVEPPR RSGKATRKKK HLEAQEDSRG
     HTLAFHDWQG PRPWENLNLS DWEVQSPIQV SGDWEHPNTP RGLSGWEGPS TSRILSGWEG
     PSASWALSAW EGPSTSRALG LSESPGSSLP VVVSEVASVS PGSSATQDNS KVEAQPLSPL
     DERANALVQF LLVKDQAKVP VQRSEMVKVI LREYKDECLD IINRANNKLE CAFGYQLKEI
     DTKNHAYIII NKLGYHTGNL VASYLDRPKF GLLMVVLSLI FMKGNCVRED LIFNFLFKLG
     LDVRETNGLF GNTKKLITEV FVRQKYLEYR RIPYTEPAEY EFLWGPRAFL ETSKMLVLRF
     LAKLHKKDPQ SWPFHYLEAL AECEWEDTDE DEPDTGDSAH GPTSRPPPR
//
